Metabolite

KNApSAcK Entry

id C00001243
Name Diallyl disulfide
CAS RN 2179-57-9
Standard InChI InChI=1S/C6H10S2/c1-3-5-7-8-6-4-2/h3-4H,1-2,5-6H2
Standard InChI (Main Layer) InChI=1S/C6H10S2/c1-3-5-7-8-6-4-2/h3-4H,1-2,5-6H2

Cluster

Phytochemical cluster
KCF-S cluster No. 6073

Link

ChEMBL

By standard InChI CHEMBL366603
By standard InChI Main Layer CHEMBL366603

KEGG

By LinkDB C08369

CTD

By CAS RN C028009

Species

Summary

Plant class

class name count
Liliopsida 2

Family

family name count
Amaryllidaceae 2

List (2)

* NCBI
KNApSAcK organism *ID *family *plant class *kingdom
Allium cepa 4679 Amaryllidaceae Liliopsida Viridiplantae
Allium sativum 4682 Amaryllidaceae Liliopsida Viridiplantae

Human Protein / Gene in interaction

11 ChEMBL Protein in interactions

accession description class description compound assay ID (# of activities) # of diseases
(OMIM / KEGG)
P11473 Vitamin D3 receptor NR1I1 CHEMBL366603 CHEMBL1794311 (1)
2 / 3
P00352 Retinal dehydrogenase 1 Enzyme CHEMBL366603 CHEMBL1614458 (1)
0 / 0
O75762 Transient receptor potential cation channel subfamily A member 1 Unclassified protein CHEMBL366603 CHEMBL1118238 (1) CHEMBL1118242 (1)
1 / 0
P15428 15-hydroxyprostaglandin dehydrogenase [NAD(+)] Enzyme CHEMBL366603 CHEMBL1614038 (1)
2 / 2
P16050 Arachidonate 15-lipoxygenase Enzyme CHEMBL366603 CHEMBL1614240 (1)
0 / 0
P08684 Cytochrome P450 3A4 Cytochrome P450 3A4 CHEMBL366603 CHEMBL1614108 (1) CHEMBL1613886 (1)
0 / 1
P05181 Cytochrome P450 2E1 Cytochrome P450 2E1 CHEMBL366603 CHEMBL1743280 (1)
0 / 0
P27695 DNA-(apurinic or apyrimidinic site) lyase Enzyme CHEMBL366603 CHEMBL1614211 (1)
0 / 0
P37088 Amiloride-sensitive sodium channel subunit alpha NA CHEMBL366603 CHEMBL2051232 (1)
2 / 2
P51168 Amiloride-sensitive sodium channel subunit beta Unclassified protein CHEMBL366603 CHEMBL2051232 (1)
3 / 3
P51170 Amiloride-sensitive sodium channel subunit gamma Unclassified protein CHEMBL366603 CHEMBL2051232 (1)
2 / 3

CTD interaction (55)

compound gene gene name gene description interaction interaction type form reference
pmid
C028009 5243 ABCB1
ABC20
CD243
CLCS
GP170
MDR1
P-GP
PGY1
ATP-binding cassette, sub-family B (MDR/TAP), member 1 (EC:3.6.3.44) diallyl disulfide results in increased expression of ABCB1 mRNA increases expression
mRNA 22397993
C028009 4363 ABCC1
ABC29
ABCC
GS-X
MRP
MRP1
ATP-binding cassette, sub-family C (CFTR/MRP), member 1 diallyl disulfide results in decreased expression of ABCC1 mRNA decreases expression
mRNA 22397993
C028009 4363 ABCC1
ABC29
ABCC
GS-X
MRP
MRP1
ATP-binding cassette, sub-family C (CFTR/MRP), member 1 diallyl disulfide results in increased expression of ABCC1 mRNA increases expression
mRNA 22397993
C028009 8714 ABCC3
ABC31
EST90757
MLP2
MOAT-D
MRP3
cMOAT2
ATP-binding cassette, sub-family C (CFTR/MRP), member 3 diallyl disulfide affects the expression of ABCC3 mRNA affects expression
mRNA 22397993
C028009 8714 ABCC3
ABC31
EST90757
MLP2
MOAT-D
MRP3
cMOAT2
ATP-binding cassette, sub-family C (CFTR/MRP), member 3 diallyl disulfide results in increased expression of ABCC3 mRNA increases expression
mRNA 22397993
C028009 10257 ABCC4
EST170205
MOAT-B
MOATB
MRP4
ATP-binding cassette, sub-family C (CFTR/MRP), member 4 diallyl disulfide results in decreased expression of ABCC4 mRNA decreases expression
mRNA 22397993
C028009 10257 ABCC4
EST170205
MOAT-B
MOATB
MRP4
ATP-binding cassette, sub-family C (CFTR/MRP), member 4 diallyl disulfide results in increased expression of ABCC4 mRNA increases expression
mRNA 22397993
C028009 368 ABCC6
ABC34
ARA
EST349056
GACI2
MLP1
MOAT-E
MOATE
MRP6
PXE
PXE1
URG7
ATP-binding cassette, sub-family C (CFTR/MRP), member 6 diallyl disulfide results in decreased expression of ABCC6 mRNA decreases expression
mRNA 22397993
C028009 368 ABCC6
ABC34
ARA
EST349056
GACI2
MLP1
MOAT-E
MOATE
MRP6
PXE
PXE1
URG7
ATP-binding cassette, sub-family C (CFTR/MRP), member 6 diallyl disulfide results in increased expression of ABCC6 mRNA increases expression
mRNA 22397993
C028009 467 ATF3
activating transcription factor 3 diallyl disulfide results in increased expression of ATF3 protein increases expression
protein 15897233
C028009 596 BCL2
Bcl-2
PPP1R50
B-cell CLL/lymphoma 2 diallyl disulfide results in decreased expression of BCL2 protein decreases expression
protein 14522920
C028009 836 CASP3
CPP32
CPP32B
SCA-1
caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) diallyl disulfide results in increased activity of CASP3 protein increases activity
protein 14522920
C028009 842 CASP9
APAF-3
APAF3
ICE-LAP6
MCH6
PPP1R56
caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62) diallyl disulfide results in increased activity of CASP9 protein increases activity
protein 14522920
C028009 857 CAV1
BSCL3
CGL3
MSTP085
PPH3
VIP21
CAV
caveolin 1, caveolae protein, 22kDa diallyl disulfide promotes the reaction [NOS3 protein binds to CAV1 protein] affects binding
/ increases reaction
protein 20229525
C028009 891 CCNB1
CCNB
cyclin B1 diallyl disulfide results in decreased expression of CCNB1 protein decreases expression
protein 16691315
C028009 891 CCNB1
CCNB
cyclin B1 diallyl disulfide results in increased expression of CCNB1 protein increases expression
protein 19202565
C028009 999 CDH1
Arc-1
CD324
CDHE
ECAD
LCAM
UVO
cadherin 1, type 1, E-cadherin (epithelial) diallyl disulfide results in decreased expression of CDH1 mRNA decreases expression
mRNA 20600798
C028009 999 CDH1
Arc-1
CD324
CDHE
ECAD
LCAM
UVO
cadherin 1, type 1, E-cadherin (epithelial) diallyl disulfide results in decreased expression of CDH1 protein decreases expression
protein 20600798
C028009 983 CDK1
CDC2
CDC28A
P34CDC2
cyclin-dependent kinase 1 (EC:2.7.11.23 2.7.11.22) diallyl disulfide results in decreased expression of CDK1 protein decreases expression
protein 16691315
C028009 9075 CLDN2
claudin 2 diallyl disulfide results in decreased expression of CLDN2 mRNA decreases expression
mRNA 20600798
C028009 9075 CLDN2
claudin 2 diallyl disulfide results in decreased expression of CLDN2 protein decreases expression
protein 20600798
C028009 1365 CLDN3
C7orf1
CPE-R2
CPETR2
HRVP1
RVP1
claudin 3 diallyl disulfide results in decreased expression of CLDN3 mRNA decreases expression
mRNA 20600798
C028009 1365 CLDN3
C7orf1
CPE-R2
CPETR2
HRVP1
RVP1
claudin 3 diallyl disulfide results in decreased expression of CLDN3 protein decreases expression
protein 20600798
C028009 1364 CLDN4
CPE-R
CPER
CPETR
CPETR1
WBSCR8
hCPE-R
claudin 4 diallyl disulfide results in decreased expression of CLDN4 mRNA decreases expression
mRNA 20600798
C028009 1364 CLDN4
CPE-R
CPER
CPETR
CPETR1
WBSCR8
hCPE-R
claudin 4 diallyl disulfide results in decreased expression of CLDN4 protein decreases expression
protein 20600798
C028009 7122 CLDN5
AWAL
BEC1
CPETRL1
TMVCF
claudin 5 diallyl disulfide results in decreased expression of CLDN5 mRNA decreases expression
mRNA 20600798
C028009 7122 CLDN5
AWAL
BEC1
CPETRL1
TMVCF
claudin 5 diallyl disulfide results in decreased expression of CLDN5 protein decreases expression
protein 20600798
C028009 1499 CTNNB1
CTNNB
MRD19
armadillo
catenin (cadherin-associated protein), beta 1, 88kDa diallyl disulfide results in increased expression of CTNNB1 mRNA increases expression
mRNA 20600798
C028009 1499 CTNNB1
CTNNB
MRD19
armadillo
catenin (cadherin-associated protein), beta 1, 88kDa diallyl disulfide results in increased expression of CTNNB1 protein increases expression
protein 20600798
C028009 1543 CYP1A1
AHH
AHRR
CP11
CYP1
P1-450
P450-C
P450DX
cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) diallyl disulfide results in decreased activity of CYP1A1 protein decreases activity
protein 18339364
C028009 1548 CYP2A6
CPA6
CYP2A
CYP2A3
CYPIIA6
P450C2A
P450PB
cytochrome P450, family 2, subfamily A, polypeptide 6 (EC:1.14.14.1) diallyl disulfide results in decreased activity of CYP2A6 protein decreases activity
protein 18339364
C028009 24300 diallyl disulfide results in increased expression of CYP2B1 mRNA increases expression
mRNA 17353348
C028009 361523 diallyl disulfide results in increased expression of CYP2B2 mRNA increases expression
mRNA 17353348
C028009 1571 CYP2E1
CPE1
CYP2E
P450-J
P450C2E
cytochrome P450, family 2, subfamily E, polypeptide 1 (EC:1.14.13.n7) diallyl disulfide results in decreased activity of CYP2E1 protein decreases activity
protein 18339364
C028009 9518 GDF15
GDF-15
MIC-1
MIC1
NAG-1
PDF
PLAB
PTGFB
growth differentiation factor 15 diallyl disulfide results in increased expression of GDF15 protein increases expression
protein 11925476
C028009 9518 GDF15
GDF-15
MIC-1
MIC1
NAG-1
PDF
PLAB
PTGFB
growth differentiation factor 15 TP53 protein affects the reaction [diallyl disulfide results in increased expression of GDF15 protein] affects reaction
/ increases expression
protein 11925476
C028009 3725 JUN
AP-1
AP1
c-Jun
jun proto-oncogene diallyl disulfide results in increased phosphorylation of JUN protein increases phosphorylation
protein 14522920
C028009 5599 MAPK8
JNK
JNK-46
JNK1
JNK1A2
JNK21B1/2
PRKM8
SAPK1
SAPK1c
mitogen-activated protein kinase 8 (EC:2.7.11.24) diallyl disulfide results in increased phosphorylation of MAPK8 protein increases phosphorylation
protein 14522920
C028009 4313 MMP2
CLG4
CLG4A
MMP-II
MONA
TBE-1
matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) (EC:3.4.24.24) diallyl disulfide results in decreased expression of and results in decreased activity of MMP2 protein decreases activity
/ decreases expression
protein 20600798
C028009 4313 MMP2
CLG4
CLG4A
MMP-II
MONA
TBE-1
matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) (EC:3.4.24.24) diallyl disulfide results in decreased expression of MMP2 mRNA decreases expression
mRNA 20600798
C028009 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) diallyl disulfide results in decreased expression of and results in decreased activity of MMP9 protein decreases activity
/ decreases expression
protein 20600798
C028009 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) diallyl disulfide results in decreased expression of MMP9 mRNA decreases expression
mRNA 20600798
C028009 4846 NOS3
ECNOS
eNOS
nitric oxide synthase 3 (endothelial cell) (EC:1.14.13.39) diallyl disulfide promotes the reaction [NOS3 protein binds to CAV1 protein] affects binding
/ increases reaction
protein 20229525
C028009 4846 NOS3
ECNOS
eNOS
nitric oxide synthase 3 (endothelial cell) (EC:1.14.13.39) diallyl disulfide results in decreased degradation of NOS3 protein decreases degradation
protein 20229525
C028009 4846 NOS3
ECNOS
eNOS
nitric oxide synthase 3 (endothelial cell) (EC:1.14.13.39) diallyl disulfide results in increased expression of NOS3 protein increases expression
protein 20229525
C028009 4846 NOS3
ECNOS
eNOS
nitric oxide synthase 3 (endothelial cell) (EC:1.14.13.39) diallyl disulfide results in increased phosphorylation of NOS3 protein increases phosphorylation
protein 20229525
C028009 4846 NOS3
ECNOS
eNOS
nitric oxide synthase 3 (endothelial cell) (EC:1.14.13.39) wortmannin inhibits the reaction [diallyl disulfide results in increased phosphorylation of NOS3 protein] decreases reaction
/ increases phosphorylation
protein 20229525
C028009 6615 SNAI1
SLUGH2
SNA
SNAH
SNAIL
SNAIL1
dJ710H13.1
snail family zinc finger 1 diallyl disulfide results in decreased expression of SNAI1 mRNA decreases expression
mRNA 20600798
C028009 6615 SNAI1
SLUGH2
SNA
SNAH
SNAIL
SNAIL1
dJ710H13.1
snail family zinc finger 1 diallyl disulfide results in decreased expression of SNAI1 protein decreases expression
protein 20600798
C028009 7076 TIMP1
CLGI
EPA
EPO
HCI
TIMP
TIMP metallopeptidase inhibitor 1 diallyl disulfide results in increased expression of TIMP1 mRNA increases expression
mRNA 20600798
C028009 7077 TIMP2
CSC-21K
DDC8
TIMP metallopeptidase inhibitor 2 diallyl disulfide results in increased expression of TIMP2 mRNA increases expression
mRNA 20600798
C028009 7157 TP53
BCC7
LFS1
P53
TRP53
tumor protein p53 Acetylcysteine inhibits the reaction [diallyl disulfide results in increased expression of TP53 protein] decreases reaction
/ increases expression
protein 19202565
C028009 7157 TP53
BCC7
LFS1
P53
TRP53
tumor protein p53 diallyl disulfide results in increased expression of TP53 protein increases expression
protein 11925476
19202565
C028009 7157 TP53
BCC7
LFS1
P53
TRP53
tumor protein p53 Glutathione inhibits the reaction [diallyl disulfide results in increased expression of TP53 protein] decreases reaction
/ increases expression
protein 19202565
C028009 7157 TP53
BCC7
LFS1
P53
TRP53
tumor protein p53 TP53 protein affects the reaction [diallyl disulfide results in increased expression of GDF15 protein] affects reaction
/ increases expression
protein 11925476

Related Disease

Diseases related to proteins in ChEMBL interactions

OMIM (10)

OMIM preferred title UniProt
#211400 Bronchiectasis with or without elevated sweat chloride 1; besc1 P51168
#613021 Bronchiectasis with or without elevated sweat chloride 2; besc2 P37088
#613071 Bronchiectasis with or without elevated sweat chloride 3; besc3 P51170
#119900 Digital clubbing, isolated congenital P15428
#615040 Episodic pain syndrome, familial, 1; feps1 O75762
#259100 Hypertrophic osteoarthropathy, primary, autosomal recessive, 1; phoar1 P15428
#177200 Liddle syndrome P51168
P51170
#607948 Mycobacterium tuberculosis, susceptibility to P11473
#264350 Pseudohypoaldosteronism, type i, autosomal recessive; pha1b P37088
P51168
#277440 Vitamin d-dependent rickets, type 2a; vddr2a P11473

KEGG DISEASE (9)

KEGG disease name UniProt
H00036 Osteosarcoma P08684 (marker)
H00342 Tuberculosis P11473 (related)
H00784 Localized autosomal recessive hypotrichosis P11473 (related)
H01143 Vitamin D-dependent rickets P11473 (related)
H00457 Primary hypertrophic osteoarthropathy (PHO) P15428 (related)
H01246 Isolated congenital nail clubbing (ICNC) P15428 (related)
H00243 Hyperkalemic distal renal tubular acidosis (RTA type 4) P37088 (related)
P51168 (related)
P51170 (related)
H00892 Bronchiectasis with or without elevated sweat chloride P37088 (related)
P51168 (related)
P51170 (related)
H00242 Liddle syndrome P51168 (related)
P51170 (related)

Diseases related to CTD interactions

5 disease from interactions of metabolites

MeSH disease OMIM compound disease name evidence type reference
pmid
D000230 C028009 Adenocarcinoma therapeutic
8339252
D003110 C028009 Colonic Neoplasms therapeutic
8339252
D007674 C028009 Kidney Diseases therapeutic
12877940
D009369 C028009 Neoplasms therapeutic
22397993
D011471 C028009 Prostatic Neoplasms therapeutic
16691315